-
A COMPREHENSIVE GLOBAL SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE OF RELAPSED/REFRACTORY AND POST-BRUTON TYROSINE KINASE INHIBITOR MANTLE CELL LYMPHOMA
Mar 18, 2026, 21:38 PM -
COMMON VS FREQUENT: ASSESSING VARIABLE DISEASE PRESENTATION IN IGAN AND C3G, THROUGH HOME-REPORTED OUTCOMES AND PATIENT-REPORTED ENDPOINTS ANALYSES
Mar 18, 2026, 21:38 PM -
RECEIPT OF SARS-COV2 MRNA VACCINE PRIOR TO IMMUNE CHECKPOINT INHIBITOR THERAPY ASSOCIATED WITH SIGNIFICANTLY IMPROVED OVERALL SURVIVAL ACROSS MULTIPLE METASTATIC CANCERS: RESULTS FROM A REAL-WORLD EVIDENCE STUDY
Mar 18, 2026, 21:38 PM -
COMPARATIVE POST-MARKETING SAFETY STUDY OF NIRSEVIMAB AND PALIVIZUMAB: A PHARMACOVIGILANCE ANALYSIS USING FAERS AND WHO VIGIACCESS
Mar 18, 2026, 21:38 PM -
EVIDENCE-BASED BENEFIT-RISK ASSESSMENT OF THE RSVPREF VACCINE IN ADULTS AGED =60 YEARS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF ORFORGLIPRON AND SEMAGLUTIDE FOR THE TREATMENT OF ADULTS WITH OBESITY IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
HEOR IN THE ABSENCE OF A CODE-BASED POPULATION DEFINITION
Mar 18, 2026, 21:38 PM -
INTEGRATING GENERATIVE ARTIFICIAL INTELLIGENCE (AI) INTO BIOSTATISTICAL WORKFLOWS FOR TRIAL EMULATION: A FRAMEWORK TO ACCELERATE REAL-WORLD EVIDENCE GENERATION
Mar 18, 2026, 21:38 PM -
EVALUATION OF OFF-THE-SHELF AGENT-BASED AI TOOL CLAUDE CODE FOR RAPID REPLICATION OF A PUBLISHED COST-EFFECTIVENESS MODEL
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR SEVERE ASTHMA: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
RISING LEVELS OF INNOVATION IN EXPEDITED DESIGNATIONS AMONG FDA-APPROVED DRUGS: 2012-2024
Mar 18, 2026, 21:38 PM -
REAL-WORLD INSIGHTS ON CONTROLLED OVARIAN STIMULATION FOR IVF/ICSI: DATA FROM A LARGE FERTILITY EMR DATABASE IN THE US (2010 - 2024)
Mar 18, 2026, 21:38 PM -
MULTI-CRITERIA DECISION ANALYSIS IN HEALTH INTERVENTION PRIORITY SETTING FOR UNIVERSAL HEALTH COVERAGE IN KENYA: AN EXPLORATORY STUDY
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION AND COSTS OF CT-BASED ROBOTIC-ARM ASSISTED VERSUS MANUAL TOTAL KNEE ARTHROPLASTY COHORTS: REAL-WORLD EVIDENCE FROM THE PREMIER HEALTHCARE DATABASE
Mar 18, 2026, 21:38 PM -
REAL-WORLD SAFETY TRENDS OF GLP-1 RECEPTOR AGONISTS IN THE UNITED STATES: ANALYSIS OF FAERS REPORTS (2015-2025)
Mar 18, 2026, 21:38 PM -
PROMISE OF REAL-WORLD DATA NETWORKS: INNOVATIONS IN TRIAL DESIGN USING PCORNET®
Mar 18, 2026, 21:38 PM -
REAL-WORLD ECONOMIC BURDEN AND HEALTHCARE UTILIZATION DRIVERS IN AUTISM SPECTRUM DISORDER: A LONGITUDINAL ANALYSIS OF EHR AND CLAIMS DATA (2017-2025)
Mar 18, 2026, 21:38 PM -
REAL-WORLD DEMOGRAPHIC AND TREATMENT CHARACTERISTICS OF PATIENTS WITH CONGENITAL MYASTHENIC SYNDROME IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
HEALTH OUTCOMES AND IMPLEMENTATION EFFECTIVENESS OF THE ANKYLOSING SPONDYLITIS RURAL HEALTH PROJECT IN CHINA: A PROSPECTIVE COHORT STUDY FROM HEALTH EQUITY PERSPECTIVE
Mar 18, 2026, 21:38 PM -
CONTENT VALIDITY OF THE EQ-HWB-9 IN PATIENTS WITH ADVANCED ILLNESSES: A COGNITIVE DEBRIEFING STUDY
Mar 18, 2026, 21:38 PM
